Coronary Artery Disease Clinical Trials
48 studies are recruiting for coronary artery disease in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 2
-
Progress Bifurcation Global Registry
Coronary bifurcation lesions are lesions (or blockages) that occur at or near the intersection of a major coronary artery and one of the arteries' side branches. Numerous techniques and devices have been developed to treat coronary bifurcations; however, these types of lesions remain some of the mo…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
- Run by
- Minneapolis Heart Institute Foundation
-
Hybrid Group Singing
The overall objective of the planned future clinical trial is to test the investigator's central hypothesis that habitual singing over several weeks, similar to habitual exercise, will lead to sustained and favorable vascular adaptation, thereby lowering cardiovascular disease (CVD) risk. The overa…
- Stage
- Not phased
- Ages
- 55 to 89
- Site
- Medical College of Wisconsin, Milwaukee, Wisconsin
- Run by
- Medical College of Wisconsin
-
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
Traditionally, the severity of a blockage (stenosis) in a coronary artery has been determined by visual angiographic assessment of the diameter of the artery at the level of a blockage compared to a normal healthy area of the same artery. With the advent of invasive physiological testing to assess …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
- Run by
- Beth Israel Deaconess Medical Center
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
Early detection of coronary atherosclerotic disease facilitates adequate prevention. The purpose of this study is to compare an assessment of coronary atherosclerotic disease burden by positron emission tomography / computed tomography (NaF-PET/CT) with those of conventional and ultra-high-resoluti…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Johns Hopkins Hospital, Baltimore, Maryland
- Run by
- Johns Hopkins University
-
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
Dual antiplatelet therapy (DAPT) with low-dose aspirin and a P2Y12 inhibitor is the current standard of care in patients with coronary artery disease experiencing an acute event or undergoing percutaneous coronary intervention. However, the ischemic benefits are counterbalanced by a significant inc…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- University of Florida, Jacksonville, Florida
- Run by
- University of Florida
-
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, stroke, and death. The p…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama
- Locations
- 9 in total
- Run by
- VA Office of Research and Development
-
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Cedars-Sinai Medical Center, Los Angeles, California
- Locations
- 146 in total
- Run by
- Weill Medical College of Cornell University
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
The goal of this clinical trial is to evaluate whether disclosure of a polygenic risk score for coronary artery disease (CAD PRS) influences cardiovascular health and risk factor modification over one year among adults aged 30-75 years in the Mass General Brigham primary care network who are not cu…
- Stage
- Not phased
- Ages
- 30 to 75
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events
The study aims to support patients immediately after percutaneous coronary intervention (PCI) by implementing a telemonitoring program. Eligible patients have coronary heart disease and undergo PCI. The intervention group receives remote monitoring and text-based follow-up, with established health …
- Stage
- Not phased
- Ages
- Any age
- Site
- University of California, Davis Medical Center Division of Cardiovascular Medicine, Sacramento, California
- Run by
- University of California, Davis
-
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
The proposed study aims to assess the antiplatelet effects of more potent oral P2Y12 inhibition with low-dose ticagrelor (60 mg bid) compared with standard of care clopidogrel in patients with a high ABCD-GENE score (≥10). We hypothesize that ticagrelor is associated with better pharmacodynamic eff…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- University of Florida Jacksonville, Jacksonville, Florida
- Run by
- University of Florida
-
Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors
Ticagrelor currently represents the most tested and commonly used P2Y12 inhibitor monotherapy following percutaneous coronary intervention. The purpose of this study is to conduct a head-to-head comparison on the pharmacodynamic efficacy of ticagrelor-based and prasugrel-based single antiplatelet t…
- Stage
- Phase 4
- Ages
- 18 to 75
- Site
- University of Florida Jacksonville, Jacksonville, Florida
- Run by
- University of Florida
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of r…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Tennessee Health Science Center/Regional One Health, Memphis, Tennessee
- Locations
- 2 in total
- Run by
- University of Tennessee
-
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intel…
- Stage
- Not phased
- Ages
- 40 to 75
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Run by
- Brigham and Women's Hospital
-
A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction
Despite the relative safety of PCI with new generation stents, peri-PCI thrombotic complications, including myocardial infarction and myocardial injury, are common in elective PCI, occurring in up to 30% of patients. Importantly, these events are associated with poor prognosis. The risk of peri-PCI…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Florida Jacksonville, Jacksonville, Florida
- Run by
- University of Florida
-
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Clearwater Cardiovascular and Interventional Consultants, Clearwater, Florida
- Locations
- 24 in total
- Run by
- Concept Medical Inc.
-
South Asians and Coronary Plaque Registry
Individuals who self-report as SAs will be recruited to participate in this registry as well as non-SA controls for comparison. All individuals who consent to participate will 1) complete a survey assessing demographics, medical history, family medical history; 2) have blood collection; 3) and CCTA…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Texas Southwestern Medical Center, Dallas, Texas
- Run by
- University of Texas Southwestern Medical Center
-
Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery
Heart disease is the leading cause of death globally, accounting for 16% of the world's total deaths. The number of cases is expected to increase as our population ages. Heart disease also results in large economic burden. It costs the United States about $219 billion per year. Some patients have s…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- University of Iowa Hospitals and Clinics, Iowa City, Iowa
- Run by
- University of Iowa
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…
- Stage
- Not phased
- Ages
- Any age
- Site
- Huntsville Heart Center, Huntsville, Alabama
- Locations
- 72 in total
- Run by
- University of British Columbia
-
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Dignity Health - Chandler Regional Medical Center, Chandler, Arizona
- Locations
- 18 in total
- Run by
- Kardion Inc
-
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure
The clinical and demographic characteristics of patients undergoing transcatheter aortic valve implantation (TAVI) pose unique challenges for coronary computed tomography (CT) imaging, as this patient population is mainly composed of elderly, frail individuals with severe aortic stenosis, multiple …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Medical University of South Carolina, Charleston, South Carolina
- Locations
- 7 in total
- Run by
- Semmelweis University
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…
- Stage
- Not phased
- Ages
- 18 to 110
- Site
- Cardiology, PC - Princeton Baptist Medical Center, Birmingham, Alabama
- Locations
- 28 in total
- Run by
- Concept Medical Inc.
-
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.
- Stage
- Not phased
- Ages
- 40 and older
- Site
- Metabolic Research Institute, Inc, West Palm Beach, Florida
- Run by
- Aventusoft, LLC.
-
Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.
Information gathered from the patients via a disease specific questionnaire will be married to data from the National Cardiovascular Data Registry (NCDR®). Details will be continuously analyzed and used to direct quality of care at our center. The institution is categorized as a low-volume institut…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Valley View Hospital, Glenwood Springs, Colorado
- Run by
- Cardiovascular Innovation and Research Institute
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.